Andhra Pradesh - Guntur   

Future is for drugs derived from biotech

Staff Reporter

GUNTUR: Biotechnology-derived drugs have a great future in healthcare, however, certain challenges like equitable distribution of vaccinations in remote and interior areas and safety issues of gene-therapy still persist, said Nektar Therapeutics Private Limited managing director Sarma P. Duddu.

Speaking at a seminar on `Environmental Biotechnology' conducted by the Jagarlamudi Kuppuswamy Chowdary (JKC) College here on Saturday, he said that the innovations in the healthcare were driven by cost efficiency and patient-friendliness.

More than 40 per cent of all the new drugs in the world were derived from biotechnology and more than 35 per cent were based on monoclonal antibodies. The stem cell-based research approaches were in their early stages of research but had a great promise.

The keynote address was given by Centre for Environment Jawaharlal Nehru Technological University Director M. Anji Reddy, who spoke on the role of Geomatics for the effective environment management.

Earlier, Nagarjuna Education Society president, K. Basavapunnaiah, inaugurated the seminar.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Future is for drugs derived from biotech

Copyright © 2006, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu